Mirum Pharma Lifts 2026 Sales Outlook on 55% LIVMARLI Growth
Mirum Pharmaceuticals raised full-year revenue guidance to $660M-$680M after Q1 net sales rose to $114M. Mirum Pharmaceuticals reported first-quarter 2026 net sales of $114 million for LIVMARLI, a 55% year-over-year increase. The company raised its full-year revenue guidan